Form 4 for CRBU Caribou Biosciences, Inc.
Accepted 2021-12-08 00:00:00 ET · period of report 2021-12-07 · accession 0001209191-21-068582 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-12-08 | 2021-12-07 | CRBU | MCCLUNG BARBARA G | CLO | P - Purchase | $2.69 | +6,127 | 349.0K | +2% | +$16.5K |
| DM | 2021-12-08 | 2021-12-07 | CRBU | MCCLUNG BARBARA G | CLO | X - OptEx | $0.00 | -6,127 | 74.8K | -8% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-07 | P | A | 12 | $2.69 | 342,856 | D | — | — | (F2) The exercise price for this stock option was incorrectly reported as $2.68 per share on the reporting person's Form 3 filed on July 22, 2021. |
| 2 | Common | Common Stock | 2021-12-07 | P | A | 6,115 | $2.69 | 348,971 | D | — | — | (F2) The exercise price for this stock option was incorrectly reported as $2.68 per share on the reporting person's Form 3 filed on July 22, 2021. |
| 3 | Derivative | Option to purchase Common Stock | 2021-12-07 | X | D | 12 | $0.00 | 77 | D | $2.69 · — to 2028-06-11 | 12 Common Stock | (F2) The exercise price for this stock option was incorrectly reported as $2.68 per share on the reporting person's Form 3 filed on July 22, 2021. (F3) The shares subject to this option have vested or will vest in equal monthly installments until the option is fully vested on June 12, 2022, subject to the reporting person's continued service to the Issuer through the applicable vesting dates. |
| 4 | Derivative | Option to purchase Common Stock | 2021-12-07 | X | D | 6,115 | $0.00 | 74,836 | D | $2.69 · — to 2029-09-30 | 6,115 Common Stock | (F2) The exercise price for this stock option was incorrectly reported as $2.68 per share on the reporting person's Form 3 filed on July 22, 2021. (F4) The shares subject to this option have vested or will vest in equal monthly installments until the option is fully vested on October 1, 2023, subject to the reporting person's continued service to the Issuer through the applicable vesting dates. |